Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
Recruiting · NCT05829629 · Registry updated 2025-02-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 1 | 2025-02-14 | NCT05829629 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BlueSky Immunotherapies GmbH | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Univerzitná nemocnica Bratislava | Bratislava | Slovakia | 1 |